Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudio Brancolini

Showing results (61-70 of 77) with videos related to

Pageof 8
Sort By:
Cell Death & Disease|February 9, 2018
The binding landscape of a partially-selective isopeptidase inhibitor with potent pro-death activity, based on the bis(arylidene)cyclohexanone scaffoldSonia Ciotti, Riccardo Sgarra, Andrea Sgorbissa, et al.
Neurobiology of Disease|June 23, 2004
Impairment of PMP22 transgenic Schwann cells differentiation in culture: implications for Charcot-Marie-Tooth type 1A diseaseLucilla Nobbio, Tiziana Vigo, Michele Abbruzzese, et al.
Molecular Biology of the Cell|November 30, 2007
PP2A regulates HDAC4 nuclear importGabriela Paroni, Nadia Cernotta, Claudio Dello Russo, et al.
Journal of Molecular Biology|March 16, 2024
Folding of Class IIa HDAC Derived Peptides into α-helices Upon Binding to Myocyte Enhancer Factor-2 in Complex with DNAMonica Chinellato, Stefano Perin, Alberto Carli, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 6, 2024
Changes in chromatin accessibility and transcriptional landscape induced by HDAC inhibitors in TP53 mutated patient-derived colon cancer organoidsTeresa Gagliano, Emanuela Kerschbamer, Umberto Baccarani, et al.
Molecular and Cellular Biology|September 18, 2013
MEF2 is a converging hub for histone deacetylase 4 and phosphatidylinositol 3-kinase/Akt-induced transformationEros Di Giorgio, Andrea Clocchiatti, Sara Piccinin, et al.
Journal of Medicinal Chemistry|February 3, 2015
Synthesis, characterization, and optimization for in vivo delivery of a nonselective isopeptidase inhibitor as new antineoplastic agentUlma Cersosimo, Andrea Sgorbissa, Carmen Foti, et al.
Plos Genetics|April 19, 2017
The co-existence of transcriptional activator and transcriptional repressor MEF2 complexes influences tumor aggressivenessEros Di Giorgio, Elisa Franforte, Sebastiano Cefalù, et al.
Oncotarget|June 4, 2016
The isopeptidase inhibitor 2cPE triggers proteotoxic stress and ATM activation in chronic lymphocytic leukemia cellsAndrea Tomasella, Raffaella Picco, Sonia Ciotti, et al.
Frontiers in Immunology|July 22, 2021
A Biological Circuit Involving Mef2c, Mef2d, and Hdac9 Controls the Immunosuppressive Functions of CD4+Foxp3+ T-Regulatory CellsEros Di Giorgio, Liqing Wang, Yan Xiong, et al.
Pageof 8

Showing results (61-70 of 77) with videos related to

Sort By:
Pageof 8
Cell Death & Disease|February 9, 2018
The binding landscape of a partially-selective isopeptidase inhibitor with potent pro-death activity, based on the bis(arylidene)cyclohexanone scaffoldSonia Ciotti, Riccardo Sgarra, Andrea Sgorbissa, et al.
Neurobiology of Disease|June 23, 2004
Impairment of PMP22 transgenic Schwann cells differentiation in culture: implications for Charcot-Marie-Tooth type 1A diseaseLucilla Nobbio, Tiziana Vigo, Michele Abbruzzese, et al.
Molecular Biology of the Cell|November 30, 2007
PP2A regulates HDAC4 nuclear importGabriela Paroni, Nadia Cernotta, Claudio Dello Russo, et al.
Journal of Molecular Biology|March 16, 2024
Folding of Class IIa HDAC Derived Peptides into α-helices Upon Binding to Myocyte Enhancer Factor-2 in Complex with DNAMonica Chinellato, Stefano Perin, Alberto Carli, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 6, 2024
Changes in chromatin accessibility and transcriptional landscape induced by HDAC inhibitors in TP53 mutated patient-derived colon cancer organoidsTeresa Gagliano, Emanuela Kerschbamer, Umberto Baccarani, et al.
Molecular and Cellular Biology|September 18, 2013
MEF2 is a converging hub for histone deacetylase 4 and phosphatidylinositol 3-kinase/Akt-induced transformationEros Di Giorgio, Andrea Clocchiatti, Sara Piccinin, et al.
Journal of Medicinal Chemistry|February 3, 2015
Synthesis, characterization, and optimization for in vivo delivery of a nonselective isopeptidase inhibitor as new antineoplastic agentUlma Cersosimo, Andrea Sgorbissa, Carmen Foti, et al.
Plos Genetics|April 19, 2017
The co-existence of transcriptional activator and transcriptional repressor MEF2 complexes influences tumor aggressivenessEros Di Giorgio, Elisa Franforte, Sebastiano Cefalù, et al.
Oncotarget|June 4, 2016
The isopeptidase inhibitor 2cPE triggers proteotoxic stress and ATM activation in chronic lymphocytic leukemia cellsAndrea Tomasella, Raffaella Picco, Sonia Ciotti, et al.
Frontiers in Immunology|July 22, 2021
A Biological Circuit Involving Mef2c, Mef2d, and Hdac9 Controls the Immunosuppressive Functions of CD4+Foxp3+ T-Regulatory CellsEros Di Giorgio, Liqing Wang, Yan Xiong, et al.
Pageof 8